Chinese Clinical Oncology ›› 2018, Vol. 23 ›› Issue (7): 648-654.
Previous Articles Next Articles
Online:
Published:
Abstract: Cancer cachexia is a cancerinduced multifactor complex syndrome. About 50%80% of patients with advanced malignant tumors suffer from cancer cachexia, which counteracts effect of antitumor therapy, reduces the quality and duration of life. The mechanism of this metabolic disorder caused by tumors, is very complicated because of its serious influence on multiorgan. As a result, the evaluation and staging of its severity become difficult things. Furthermore, the intervention means to ameliorate cancer cachexia are limited at present while so much disagreement of views on treatment exists. The individualized, multidisciplinary, multimodal therapies are now advocated in clinical practice. In this paper, we shall review the progress in researches from the aspects of mechanism, evaluation and clinical medication of cancer cachexia.
Key words: Cancer cachexia, Pathogenesis, Stage evaluation, Intervention and medication
LIU Huiquan, YU Shiying. . Progression in pathogenesis and clinical diagnosis and treatment of cancer cachexia[J].Chinese Clinical Oncology, 2018, 23(7): 648-654.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://manu65.magtech.com.cn/Jwk3_lczlxzz/EN/
http://manu65.magtech.com.cn/Jwk3_lczlxzz/EN/Y2018/V23/I7/648
Cited